Talphera (TLPH) Net Income towards Common Stockholders (2010 - 2025)

Talphera's (TLPH) quarterly Net Income towards Common Stockholders came in at $73000.0 in Q1 2025, up 101.62% quarter-over-quarter from -$4.5 million in Q4 2023.

Talphera (TLPH) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends

Talphera's Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at $73000.0 for Q1 2025.

  • On a quarterly basis, Net Income towards Common Stockholders changed N/A year-over-year to $73000.0 in Q1 2025; TTM through Dec 2025 was $73000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $73000.0, changed N/A from the prior year.
  • Net Income towards Common Stockholders rose to $73000.0 in Q1 2025 per TLPH's latest filing, from -$4.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $63.2 million in Q2 2022 and bottomed at -$9.9 million in Q2 2021.
  • The 4-year median for Net Income towards Common Stockholders is -$4.5 million (2023), against an average of $698076.9.
  • Across the five-year window, Net Income towards Common Stockholders surged 741.07% in 2022 and slumped 106.92% in 2023, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$7.9 million in 2021, then soared by 34.37% to -$5.2 million in 2022, then gained by 13.3% to -$4.5 million in 2023, then jumped by 101.62% to $73000.0 in 2025.
  • Per Business Quant, the three latest TLPH Net Income towards Common Stockholders figures stand at $73000.0 (Q1 2025), -$4.5 million (Q4 2023), and -$1.4 million (Q3 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.51 Bn 30.57 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.18 Bn 21.03 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn 57.00 Mn
10 Talphera 91.82 Mn 91.82 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 73,000.00
Dec 31, 2023 -4.51 Mn
Sep 30, 2023 -1.42 Mn
Jun 30, 2023 -4.37 Mn
Mar 31, 2023 8.22 Mn
Dec 31, 2022 -5.20 Mn
Sep 30, 2022 -6.94 Mn
Jun 30, 2022 63.15 Mn
Mar 31, 2022 -4.06 Mn
Dec 31, 2021 -7.92 Mn
Sep 30, 2021 -8.38 Mn
Jun 30, 2021 -9.85 Mn
Mar 31, 2021 -9.74 Mn
Dec 31, 2020 -8.92 Mn
Sep 30, 2020 -8.93 Mn
Jun 30, 2020 -6.61 Mn
Mar 31, 2020 -16.77 Mn
Dec 31, 2019 -14.42 Mn
Sep 30, 2019 -12.73 Mn
Jun 30, 2019 -12.41 Mn